Open the reader
Friday 23 October 2026 · N° 6
France
Saturday under heavy guard
Only union marches allowed on Saturday? The right to protest, a constitutional right?
On Thursday at the Élysée, Emmanuel Macron came out of a security council with one instruction: “the general recommendation is that there should be no demonstrations in the coming days”. For Saturday’s day of action on the cost of living, only the unions will be allowed to march, on routes that skirt the city centres. Lyon and Marseille are closed to marches, and so is central Lille.
Lula’s camp accuses Meta of favouring Flávio Bolsonaro ahead of Sunday’s run-off.
On Monday, outside Meta’s offices in São Paulo, a few dozen demonstrators denounced “abusive interference in Brazilian democracy”. Sérgio Amadeu, a professor at the Federal University of ABC, is one of the organisers. On Sunday, Lula, the sitting president running for a fourth term, faces Flávio Bolsonaro, a far-right senator and son of Jair Bolsonaro, in the run-off.
Moderna and Merck’s personalised vaccine cuts the risk of relapse by 42%; the share price drops 25%.
In Madrid, the results leaked ahead of time. Moderna and Merck presented on Thursday the trial of their messenger RNA vaccine against melanoma, intismeran autogene. Combined with Keytruda, Merck’s immunotherapy, it cuts the risk of relapse or death by 42% compared with Keytruda alone, after a median follow-up of 24.6 months, in patients who have had surgery.
France · page 2
On Saturday 24 October, only demonstrations organised by the unions will be allowed.
80,000
Lyon, Marseille and central Lille are closed to marches; Paris gets a single route. Since 17 October, 2,700 people have been taken into custody and 217 jailed.
Read the articleGeopolitics · page 3
On Sunday 25 October, Brazil’s run-off: Lula against Flávio Bolsonaro.
1,600
His camp accuses Meta of favouring his rival; Meta denies it and speaks of technical incidents. A study counts at least 1,600 irregular political ads on its platforms.
Read the articlePharma & health · page 4
Moderna and Merck’s vaccine works, and Moderna’s shares lose 25%.
42%
It is made for each patient, from the proteins specific to their tumour. In line with expectations, the result cost Moderna’s shares close to 25%.
Read the articleAt first, I printed this paper for myself alone, every morning. I wanted to know what mattered in France, in Paris and in the world without spending an hour scrolling through screens. So I sorted, then I wrote.
filou d’actu is that sorting, shared. A few topics chosen every day, told simply, with the names of the media the facts come from. You read it with your coffee, from start to finish, then get on with your day.
Logan Monnet
A question? Call Logan Monnet
+33 6 62 06 11 84